TRXADE HEALTH INC (MEDS)
US89846A4058 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.72M | -3.91M | -5.32M | -2.54M | -280.00K | |||
| Depreciation Amortization | 834.17K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Change In Working Capital | 5.66M | 440.00K | 1.08M | -3.60M | -670.00K | |||
| Interest Paid | 733.69K | 340.00K | 30.00K | 30.00K | 100.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 5.15M | 1.93M | 1.66M | 3.91M | 1.09M | |||
| OPERATING CASH FLOW | -2.07M | -1.53M | -2.57M | -2.21M | 140.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -450.00K | -20.00K | -40.00K | -80.00K | |||
| Other Investing Activity | -275.72K | 20.00K | N/A | N/A | -250.00K | |||
| INVESTING CASH FLOW | -275.72K | -430.00K | -20.00K | -40.00K | -330.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 250.00K | 0.00 | -230.00K | 0.00 | -260.00K | |||
| Stock Issued/Repurchased | 1.62K | 130.00K | 20.00K | 6.03M | 2.46M | |||
| Other Financing Activity | 1.15M | -170.00K | 0.00 | -730.00K | N/A | |||
| FINANCING CASH FLOW | 1.41M | -40.00K | -210.00K | 5.30M | 2.19M | |||
| CHANGE IN CASH | -942.99K | -2.00M | -2.80M | 3.05M | 2.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.07M | -1.53M | -2.57M | -2.21M | 140.00K | |||
| Capital Expenditure | N/A | -450.00K | -20.00K | -40.00K | -80.00K | |||
| FREE CASH FLOW | -2.07M | -1.98M | -2.59M | -2.25M | 60.00K | |||
All data in USD